“…Alternatively or additionally, the preferential occurrence of certain prokaryotic biomarkers in the IOM could arise from different diagenetic fates associated with different IP moieties. For example, archaeol—which occurred only in solvent extracts of peat (Chaves Torres & Pancost, ) and marine sediments (Chaves Torres et al., )—typically contains phosphatidyl moieties (XV) (e.g., Lipp & Hinrichs, ; Peterse et al., ; Sturt, Summons, Smith, Elvert, & Hinrichs, ), whereas i‐GDGTs frequently occur as glycolipids (XVI) (Lengger, Hopmans, Sinninghe Damsté, & Schouten, ; Liu, Lipp, & Hinrichs, ; Schouten et al., ) and have been frequently reported in both soluble and IOM fractions (Chaves Torres & Pancost, ; Chaves Torres et al., ; Huguet, Fosse, Metzger, Fritsch, & Derenne, ; Tierney et al., ; Weijers et al., ). On the contrary, in hydrothermal environments archaeol has typically been reported not only as a phospholipid (XV)but also as a glycolipid (XVI) (Bradley, Fredricks, Hinrichs, & Summons, ), or only as a glycolipid (Gibson et al., ; Sollich et al., ), potentially an adaptation strategy in response to higher temperature or lower pH (Baba et al., ; Curatolo, ; Shimada et al., ; Sollich et al., ; Wang et al., ).…”